Effect of sympathetic denervation on the rate of protein synthesis in rat skeletal muscle.
Rates of protein synthesis were investigated in skeletal muscles from rats submitted to chemical and surgical sympathectomy. Three models of sympathetic denervation were used: 1) treatment with guanethidine (100 mg.kg(-1).day(-1) sc); 2) lumbar sympathetic denervation (surgical excision of the second and third lumbar ganglia of the sympathetic chain, from which arises the postganglionic fibers to the skeletal muscles of rat hindlimb); and 3) adrenodemedullation. Protein synthesis was estimated in isolated soleus muscle by the rate of incorporation of [(14)C]tyrosine (0.1 mM, 0.05 microCi/ml) into total protein. Soleus isolated after 2 and 4 days of chemical sympathectomy or after 3 days of lumbar denervation showed a 17-20% statistically significant decrease in in vitro rates of protein synthesis. These effects were reverted by addition of 10(-5) M isoproterenol or epinephrine in vitro. Neither clenbuterol nor isoproterenol (10(-7), 10(-6), or 10(-5) M) in vitro affected the rate of protein synthesis in soleus from normal rats. On the other hand, clenbuterol or epinephrine (10(-5) M) increased by 20% the rate of protein synthesis in soleus muscles from adrenodemedullated rats and prevented its decrease in muscles from fasted rats. The data suggest that the sympathetic nervous system stimulates protein synthesis in oxidative muscles, probably through the activation of beta(2)-adrenoceptors, especially in situations of hormonal or nutritional deficiency.
Navegantes
Luiz Carlos C
LC
Department of Biochemistry, School of Medicine, University of São Paulo, 14049-900 Ribeirão Preto, São Paulo, Brazil.
Resano
Neusa M Z
NM
Baviera
Amanda M
AM
Migliorini
Renato H
RH
Kettelhut
Isis C
IC
D000313:Adrenal Medulla / Q000187:drug effects / Q000378:metabolism; D018663:Adrenergic Agents / Q000494:pharmacology; D000318:Adrenergic beta-Agonists / Q000494:pharmacology; D000818:Animals; D001786:Blood Glucose / Q000378:metabolism; D002395:Catecholamines / Q000097:blood / Q000378:metabolism / Q000494:pharmacology; D002976:Clenbuterol / Q000494:pharmacology; D003345:Corticosterone / Q000097:blood; D005215:Fasting / Q000378:metabolism; D006145:Guanethidine / Q000494:pharmacology; D007545:Isoproterenol / Q000494:pharmacology; D007700:Kinetics; D008297:Male; D009124:Muscle Proteins / Q000096:biosynthesis*; D018482:Muscle, Skeletal / Q000187:drug effects / Q000294:innervation* / Q000378:metabolism*; D051381:Rats; D017208:Rats, Wistar; D013562:Sympathectomy; D014443:Tyrosine / Q000378:metabolism
D018663:Adrenergic Agents; D000318:Adrenergic beta-Agonists; D001786:Blood Glucose; D002395:Catecholamines; D009124:Muscle Proteins; D014443:Tyrosine; D007545:Isoproterenol; D003345:Corticosterone; D002976:Clenbuterol; D006145:Guanethidine